Piperazine

哌嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePiperazine
Drug Alias Name哌吡嗪六氢吡嗪双二甲胺四甲二胺二乙基二胺 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoughEnterobiasisAscariasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Emeishan Pharmaceutical Co LtdDi'Ao Group Chengdu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoughEnterobiasisAscariasis
Inactive IndicationsN/A

Other Information

ATC CodeP02CB01
Related LinksWikipediaDrugBankKEGG